On May 2, 2025, Oragenics, Inc. appointed Janet Huffman as CEO while continuing as CFO, with a base salary of $325,000 and potential bonuses; shareholders also approved a reverse stock split of 1-for-5 to 1-for-50 and an increase in the number of available shares for incentive plans to 3,166,667.